规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
Other Sizes |
|
靶点 |
USP7 (IC50 = 1.4 μM)
|
---|---|
体外研究 (In Vitro) |
USP7 or HAUSP (herpesvirus-associated USP) is a deubiquitylating enzyme that cleaves ubiquitin from its substrates. It is also known as a ubiquitin-specific protease. USP7 is a eubiquitinase (DUB) that modifies the stability of Mdm2, p53, PTEN, and FOXO4 in order to regulate cell proliferation[1].
|
体内研究 (In Vivo) |
GNE-131 exhibits poor clearance in mice, rats, and dogs when in vivo.
GNE-131 shows outstanding effectiveness in a transgenic mouse model of pain as well. |
参考文献 |
分子式 |
C20H20N4O2-HCL
|
|
---|---|---|
分子量 |
348.406
|
|
精确质量 |
348.16
|
|
元素分析 |
C, 68.95; H, 5.79; N, 16.08; O, 9.18
|
|
CAS号 |
2009273-60-1
|
|
相关CAS号 |
|
|
外观&性状 |
Solid powder
|
|
SMILES |
O=C(C1=CC=C(C2=C(CC)C(C3=CC=C(O)C=C3)=C(N)N=C2)C=N1)NC
|
|
InChi Key |
UCYSSYGGXOFJKK-UHFFFAOYSA-N
|
|
InChi Code |
InChI=1S/C20H20N4O2/c1-3-15-16(13-6-9-17(23-10-13)20(26)22-2)11-24-19(21)18(15)12-4-7-14(25)8-5-12/h4-11,25H,3H2,1-2H3,(H2,21,24)(H,22,26)
|
|
化学名 |
6'-Amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-[3,3'-bipyridine]-6-carboxamide
|
|
别名 |
|
|
HS Tariff Code |
2934.99.03.00
|
|
存储方式 |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
运输条件 |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
溶解度 (体外) |
|
---|
制备储备液 | 1 mg | 5 mg | 10 mg | |
1 mM | 2.8702 mL | 14.3509 mL | 28.7018 mL | |
5 mM | 0.5740 mL | 2.8702 mL | 5.7404 mL | |
10 mM | 0.2870 mL | 1.4351 mL | 2.8702 mL |
1、根据实验需要选择合适的溶剂配制储备液 (母液):对于大多数产品,InvivoChem推荐用DMSO配置母液 (比如:5、10、20mM或者10、20、50 mg/mL浓度),个别水溶性高的产品可直接溶于水。产品在DMSO 、水或其他溶剂中的具体溶解度详见上”溶解度 (体外)”部分;
2、如果您找不到您想要的溶解度信息,或者很难将产品溶解在溶液中,请联系我们;
3、建议使用下列计算器进行相关计算(摩尔浓度计算器、稀释计算器、分子量计算器、重组计算器等);
4、母液配好之后,将其分装到常规用量,并储存在-20°C或-80°C,尽量减少反复冻融循环。
计算结果:
工作液浓度: mg/mL;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL)。如该浓度超过该批次药物DMSO溶解度,请首先与我们联系。
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
(1) 请确保溶液澄清之后,再加入下一种溶剂 (助溶剂) 。可利用涡旋、超声或水浴加热等方法助溶;
(2) 一定要按顺序加入溶剂 (助溶剂) 。
Identification and characterization of USP7 inhibitors.Nature.2017 Oct 26;550(7677):534-538. th> |
---|
Selectivity of USP7 inhibitors and synergy with PIM kinase inhibition. USP7 inhibitors compete with ubiquitin binding to USP7.Nature.2017 Oct 26;550(7677):534-538. td> |
USP7 preferentially binds and cleaves ubiquitin moieties with free K48 side chains.Nature.2017 Oct 26;550(7677):534-538. td> |